pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Increased glucose availability sensitizes pancreatic

Name: pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Increased glucose availability sensitizes pancreatic
Brand: iglepidom.org
SKU: 13347396143
Price: 23.37 USD
Availability: InStock
Rating: 4.7317 (7 reviews)

Increased glucose availability sensitizes pancreatic cancer to chemotherapy bioRxiv Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants Cold Spring Harbor Laboratory Application of glutathione depletion in cancer therapy: Enhanced ROS based therapy, ferroptosis, and chemotherapy ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies PMC

SKU: 13347396143 · From iglepidom.org

4.7

USD23.37 USD49.37

Pay in 4 interest-free payments of $5.84 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Albert AE, Adua SJ, Cai WL, Arnal-Estap A, Cline GW, Liu Z, et al

In a first-in-human clinical trial (NCT02491281), LNA043 was administered via intra-articular injection before total knee replacement, and results showed that LNA043 could reverse the transcriptome signature associated with osteoarthritis by promoting the expression of hyaline cartilage matrix components and anabolic signaling pathways [435]